Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Roth

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Biotechnology Annual Review|September 19, 2007
Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation EngineeringG Wesley Hatfield, David A Roth
Blood|April 26, 2003
The vitamin K-dependent gamma-glutamyl carboxylase gene contains a TATA-less promoter with a novel upstream regulatory elementElizabeth E Romero, Umaima Marvi, Zachary E Niman, et al.
American Journal of Therapeutics|May 14, 2005
A one-year comparison of cost and outcomes of angioplasty in stent and nonstent patientsShuvayu S Sen, Rezaul K Khandker, David A Roth, et al.
Journal of Comparative Effectiveness Research|April 26, 2018
An indirect comparison of intravenous and subcutaneous belimumab efficacy in patients with SLE and high disease activitySulabha Ramachandran, Daniel Parks, Milena Kurtinecz, et al.
Pharmacogenetics and Genomics|May 7, 2019
Pharmacogenetic analysis of belimumab fails to identify robust genetic predictors of efficacy in lupusPamela L St Jean, David A Roth, Linda C McCarthy, et al.
The Annals of Pharmacotherapy|March 16, 2002
Reimbursement claims analysis of outcomes with carvedilol and metoprololAileen B Luzier, Laura A Antell, Li-Ling Chang, et al.
Lupus Science & Medicine|February 8, 2022
Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLEHerbert Struemper, Milena Kurtinecz, Lisa Edwards, et al.
Structure (London, England : 1993)|April 11, 2008
Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complexJacky Chi Ki Ngo, Mingdong Huang, David A Roth, et al.
Lupus Science & Medicine|March 24, 2023
Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial dataDavid D'Cruz, Gina Eriksson, Yulia Green, et al.
Lupus Science & Medicine|February 11, 2021
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programmeToni Maslen, Ian N Bruce, David D'Cruz, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Biotechnology Annual Review|September 19, 2007
Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation EngineeringG Wesley Hatfield, David A Roth
Blood|April 26, 2003
The vitamin K-dependent gamma-glutamyl carboxylase gene contains a TATA-less promoter with a novel upstream regulatory elementElizabeth E Romero, Umaima Marvi, Zachary E Niman, et al.
American Journal of Therapeutics|May 14, 2005
A one-year comparison of cost and outcomes of angioplasty in stent and nonstent patientsShuvayu S Sen, Rezaul K Khandker, David A Roth, et al.
Journal of Comparative Effectiveness Research|April 26, 2018
An indirect comparison of intravenous and subcutaneous belimumab efficacy in patients with SLE and high disease activitySulabha Ramachandran, Daniel Parks, Milena Kurtinecz, et al.
Pharmacogenetics and Genomics|May 7, 2019
Pharmacogenetic analysis of belimumab fails to identify robust genetic predictors of efficacy in lupusPamela L St Jean, David A Roth, Linda C McCarthy, et al.
The Annals of Pharmacotherapy|March 16, 2002
Reimbursement claims analysis of outcomes with carvedilol and metoprololAileen B Luzier, Laura A Antell, Li-Ling Chang, et al.
Lupus Science & Medicine|February 8, 2022
Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLEHerbert Struemper, Milena Kurtinecz, Lisa Edwards, et al.
Structure (London, England : 1993)|April 11, 2008
Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complexJacky Chi Ki Ngo, Mingdong Huang, David A Roth, et al.
Lupus Science & Medicine|March 24, 2023
Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial dataDavid D'Cruz, Gina Eriksson, Yulia Green, et al.
Lupus Science & Medicine|February 11, 2021
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programmeToni Maslen, Ian N Bruce, David D'Cruz, et al.
Pageof 6